Widespread body pain and mortality: prospective population based study

Gary John MacFarlane, J. McBeth, A. J. Silman

Research output: Contribution to journalEditorial

172 Citations (Scopus)

Abstract

Objective To determine whether there is excess mortality in groups of people who report widespread body pain, and if so to establish the nature and extent of any excess.

Design Prospective follow up study over eight years. Mortality rate ratios were adjusted for age group, sex, and study location.

Setting North west England. Participants 6569 people who took part in two pain surveys during 1991-2.

Main outcome measures Pain status at baseline and subsequent mortality.

Results 1005 (15%) participants had widespread pain, 3176 (48%) had regional pain, and 2388 (36%) had no pain. During follow up mortality was higher in people with regional pain (mortality rate ratio 1.21, 95% confidence interval 1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those who reported no pain. The excess mortality among people with regional and widespread pain was almost entirely related to deaths from cancer (1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for widespread pain). The excess cancer mortality remained after exclusion of people in whom cancer had been diagnosed before the original survey and after adjustment for potential confounding factors. There were also more deaths from causes other than disease (for example, accidents, suicide, violence) among people with widespread pain (5.21, 0.94 to 28.78).

Conclusion There is an intriguing association between the report of widespread pain and subsequent death from cancer in the medium and long term. This may have implications for the long term follow up of patients with "unexplained widespread pain symptoms, such as those with fibromyalgia.

Original languageEnglish
Pages (from-to)662-665
Number of pages3
JournalBritish Medical Journal
Volume323
Issue number7314
DOIs
Publication statusPublished - Sep 2001

Keywords

  • LOW-BACK-PAIN
  • GENERAL-POPULATION
  • FIBROMYALGIA SYNDROME
  • PREVALENCE
  • CANCER

Cite this

Widespread body pain and mortality: prospective population based study. / MacFarlane, Gary John; McBeth, J.; Silman, A. J.

In: British Medical Journal, Vol. 323, No. 7314, 09.2001, p. 662-665.

Research output: Contribution to journalEditorial

MacFarlane, Gary John ; McBeth, J. ; Silman, A. J. / Widespread body pain and mortality: prospective population based study. In: British Medical Journal. 2001 ; Vol. 323, No. 7314. pp. 662-665.
@article{cbed4c12988a4858a5a5f7fedf7234fa,
title = "Widespread body pain and mortality: prospective population based study",
abstract = "Objective To determine whether there is excess mortality in groups of people who report widespread body pain, and if so to establish the nature and extent of any excess.Design Prospective follow up study over eight years. Mortality rate ratios were adjusted for age group, sex, and study location.Setting North west England. Participants 6569 people who took part in two pain surveys during 1991-2.Main outcome measures Pain status at baseline and subsequent mortality.Results 1005 (15{\%}) participants had widespread pain, 3176 (48{\%}) had regional pain, and 2388 (36{\%}) had no pain. During follow up mortality was higher in people with regional pain (mortality rate ratio 1.21, 95{\%} confidence interval 1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those who reported no pain. The excess mortality among people with regional and widespread pain was almost entirely related to deaths from cancer (1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for widespread pain). The excess cancer mortality remained after exclusion of people in whom cancer had been diagnosed before the original survey and after adjustment for potential confounding factors. There were also more deaths from causes other than disease (for example, accidents, suicide, violence) among people with widespread pain (5.21, 0.94 to 28.78).Conclusion There is an intriguing association between the report of widespread pain and subsequent death from cancer in the medium and long term. This may have implications for the long term follow up of patients with {"}unexplained widespread pain symptoms, such as those with fibromyalgia.",
keywords = "LOW-BACK-PAIN, GENERAL-POPULATION, FIBROMYALGIA SYNDROME, PREVALENCE, CANCER",
author = "MacFarlane, {Gary John} and J. McBeth and Silman, {A. J.}",
year = "2001",
month = "9",
doi = "10.1136/bmj.323.7314.662",
language = "English",
volume = "323",
pages = "662--665",
journal = "BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7314",

}

TY - JOUR

T1 - Widespread body pain and mortality: prospective population based study

AU - MacFarlane, Gary John

AU - McBeth, J.

AU - Silman, A. J.

PY - 2001/9

Y1 - 2001/9

N2 - Objective To determine whether there is excess mortality in groups of people who report widespread body pain, and if so to establish the nature and extent of any excess.Design Prospective follow up study over eight years. Mortality rate ratios were adjusted for age group, sex, and study location.Setting North west England. Participants 6569 people who took part in two pain surveys during 1991-2.Main outcome measures Pain status at baseline and subsequent mortality.Results 1005 (15%) participants had widespread pain, 3176 (48%) had regional pain, and 2388 (36%) had no pain. During follow up mortality was higher in people with regional pain (mortality rate ratio 1.21, 95% confidence interval 1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those who reported no pain. The excess mortality among people with regional and widespread pain was almost entirely related to deaths from cancer (1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for widespread pain). The excess cancer mortality remained after exclusion of people in whom cancer had been diagnosed before the original survey and after adjustment for potential confounding factors. There were also more deaths from causes other than disease (for example, accidents, suicide, violence) among people with widespread pain (5.21, 0.94 to 28.78).Conclusion There is an intriguing association between the report of widespread pain and subsequent death from cancer in the medium and long term. This may have implications for the long term follow up of patients with "unexplained widespread pain symptoms, such as those with fibromyalgia.

AB - Objective To determine whether there is excess mortality in groups of people who report widespread body pain, and if so to establish the nature and extent of any excess.Design Prospective follow up study over eight years. Mortality rate ratios were adjusted for age group, sex, and study location.Setting North west England. Participants 6569 people who took part in two pain surveys during 1991-2.Main outcome measures Pain status at baseline and subsequent mortality.Results 1005 (15%) participants had widespread pain, 3176 (48%) had regional pain, and 2388 (36%) had no pain. During follow up mortality was higher in people with regional pain (mortality rate ratio 1.21, 95% confidence interval 1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those who reported no pain. The excess mortality among people with regional and widespread pain was almost entirely related to deaths from cancer (1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for widespread pain). The excess cancer mortality remained after exclusion of people in whom cancer had been diagnosed before the original survey and after adjustment for potential confounding factors. There were also more deaths from causes other than disease (for example, accidents, suicide, violence) among people with widespread pain (5.21, 0.94 to 28.78).Conclusion There is an intriguing association between the report of widespread pain and subsequent death from cancer in the medium and long term. This may have implications for the long term follow up of patients with "unexplained widespread pain symptoms, such as those with fibromyalgia.

KW - LOW-BACK-PAIN

KW - GENERAL-POPULATION

KW - FIBROMYALGIA SYNDROME

KW - PREVALENCE

KW - CANCER

U2 - 10.1136/bmj.323.7314.662

DO - 10.1136/bmj.323.7314.662

M3 - Editorial

VL - 323

SP - 662

EP - 665

JO - BMJ

JF - BMJ

SN - 0959-8146

IS - 7314

ER -